NCT05457842View on ClinicalTrials.gov

A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery

PHASE2TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

September 2, 2022

Study Completion Date

September 20, 2022

Conditions
Sentinel Lymph Node BiopsyBreast CancerMelanoma
Interventions
DRUG

pudexacianinium chloride

Intradermal injection

Trial Locations (1)

92868

UCI Irvine Health-Chao Family Comprehensive Cancer Center Cancer, Orange

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY